Evidence map›Paper›PMID 31936297›Full record

ReviewCells2020

Dysfunctional Mechanotransduction through the YAP/TAZ/Hippo Pathway as a Feature of Chronic Disease.

Mathias Cobbaut, Simge Karagil, Lucrezia Bruno, Maria Del Carmen Diaz de la Loza, Francesca E Mackenzie, Michael Stolinski, Ahmed Elbediwy

Abstract readReview
In one paragraph

Review in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. iScience · 2025
    Article
  8. Review
  9. Article
  10. CRB2 depletion induces YAP signaling and disrupts mechanosensing in podocytes.American journal of physiology. Renal physiology · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mathias CobbautProtein Phosphorylation Lab, Francis Crick Institute, London NW1 1AT, UK.
Simge KaragilDepartment of Biomolecular Sciences, Kingston University, Kingston-upon-Thames KT1 2EE, UK.
Lucrezia BrunoDepartment of Biomolecular Sciences, Kingston University, Kingston-upon-Thames KT1 2EE, UK.
Maria Del Carmen Diaz de la LozaEpithelial Biology Lab, Francis Crick Institute, London NW1 1AT, UK.
Francesca E MackenzieDepartment of Chemical and Pharmaceutical Sciences, Kingston University, Kingston-upon-Thames KT1 2EE, UK.
Michael StolinskiDepartment of Biomolecular Sciences, Kingston University, Kingston-upon-Thames KT1 2EE, UK.
Ahmed ElbediwyDepartment of Biomolecular Sciences, Kingston University, Kingston-upon-Thames KT1 2EE, UK.

Funding

Cancer Research UK FC001130Medical Research Council FC001130Wellcome Trust FC001130
6 · The paper itself

Abstract

In order to ascertain their external environment, cells and tissues have the capability to sense and process a variety of stresses, including stretching and compression forces. These mechanical forces, as experienced by cells and tissues, are then converted into biochemical signals within the cell, leading to a number of cellular mechanisms being activated, including proliferation, differentiation and migration. If the conversion of mechanical cues into biochemical signals is perturbed in any way, then this can be potentially implicated in chronic disease development and processes such as neurological disorders, cancer and obesity. This review will focus on how the interplay between mechanotransduction, cellular structure, metabolism and signalling cascades led by the Hippo-YAP/TAZ axis can lead to a number of chronic diseases and suggest how we can target various pathways in order to design therapeutic targets for these debilitating diseases and conditions.

Indexed as

Mechanotransduction, CellularAcyltransferasesCell Cycle ProteinsChronic DiseaseHippo Signaling PathwayHumansProtein Serine-Threonine KinasesSignal TransductionTranscription FactorsAcyltransferasesCell Cycle ProteinsProtein Serine-Threonine KinasesTAFAZZIN protein, humanTranscription FactorsYY1AP1 protein, humanaPKCcancerHippointegrinsmechanotransductionneurodegenerative diseaseobesitypolaritytalinTAZYAP

Identifiers

PMID31936297
PMCPMC7016982

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.